NIM
MDGL icon

NEOS Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

NEOS Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,571
Closed -$915K – 622
2025
Q4 		$915K Sell
1,571
-50
-3% -$25.5K 0.01% 562
2025
Q3 		$743K Sell
1,621
-180
-10% -$67.2K 0.01% 549
2025
Q2 		$545K Sell
1,801
-477
-21% -$142K 0.01% 534
2025
Q1 		$755K Sell
2,278
-1,342
-37% -$441K 0.01% 473
2024
Q4 		$1.12M Sell
3,620
-1,358
-27% -$382K 0.03% 388
2024
Q3 		$1.06M Buy
4,978
+380
+8% +$97.2K 0.03% 367
2024
Q2 		$1.29M Sell
4,598
-983
-18% -$234K 0.05% 291
2024
Q1 		$1.49M Buy
5,581
+3,689
+195% +$869K 0.09% 203
2023
Q4 		$438K Buy
+1,892
New +$331K 0.04% 310

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NEOS Investment Management's MDGL Position: Q1 2026 in Review

NEOS Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2026, closing a stake of 1,571 shares — an estimated $915K sold.

NEOS Investment Management first reported a position in MDGL in Q4 2023 and held it in 9 quarters. The position peaked at $1.49M in Q1 2024. 380 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • NEOS Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 1,571 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $915K.
  • NEOS Investment Management first reported a position in Madrigal Pharmaceuticals in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Madrigal Pharmaceuticals position peaked at $1.49M in Q1 2024.
  • 380 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.